Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 1,000
- Avg volume
- 4,226
- Day's range
- $0.00 – $0.00
- Shares out
- —
- Stochastic %K
- 94%
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe. Its product portfolio includes the Satipharm delivery system for cannabinoids. The company was founded in 2014 and is based in Mildura, Australia.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Phone
- 61 3 9095 7088
- Website
- https://www.canngrouplimited.com
- Address
- 23 Greentek Court, Koorlong, Mildura, Australia
Latest news
No headlines yet.
